Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)

STO:NEWBRY Balance Sheet

Financials in millions SEK. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	11.67	15.3	8.53	33.33	13.15
Cash & Short-Term Investments	11.67	15.3	8.53	33.33	13.15
Cash Growth	-24.36%	79.44%	-74.42%	153.59%	-
Accounts Receivable	-	15.24	9.12	0	1.08
Other Receivables	25.63	7.01	6.39	0.79	1.25
Receivables	25.63	22.25	15.51	0.79	2.33
Inventory	8.43	5	2.11	1.77	-
Prepaid Expenses	-	1.42	1.09	0.58	0.29
Total Current Assets	45.73	43.97	27.24	36.47	15.77
Goodwill	-	1.26	2.13	3.04	3.95
Other Intangible Assets	47.12	45.64	43.55	47.39	23.09
Total Assets	92.85	90.87	72.92	86.91	42.81
Accounts Payable	-	1.94	4.28	2.04	1.88
Accrued Expenses	-	6.28	3.19	0.89	2.23
Current Income Taxes Payable	-	0.08	0.16	0.18	0.07
Current Unearned Revenue	-	-	1.63	-	-
Other Current Liabilities	30.43	21.14	2.52	2.96	0.16
Total Current Liabilities	30.43	29.45	11.77	6.06	4.34
Other Long-Term Liabilities	8.9	9.51	11.77	12.08	-
Total Liabilities	39.33	38.95	23.54	18.14	4.34
Common Stock	53.52	0.77	0.62	0.62	0.16
Additional Paid-In Capital	-	106.72	88.71	88.71	43.89
Comprehensive Income & Other	-	-55.58	-39.96	-20.57	-5.58
Shareholders' Equity	53.52	51.92	49.38	68.77	38.47
Total Liabilities & Equity	92.85	90.87	72.92	86.91	42.81
Net Cash (Debt)	11.67	15.3	8.53	33.33	13.15
Net Cash Growth	-24.36%	79.44%	-74.42%	153.59%	-
Net Cash Per Share	0.48	0.71	0.44	1.87	-
Filing Date Shares Outstanding	26.55	24.26	19.52	19.52	15.68
Total Common Shares Outstanding	26.55	24.26	19.52	19.52	15.68
Working Capital	15.3	14.53	15.47	30.42	11.43
Book Value Per Share	2.02	2.14	2.53	3.52	2.45
Tangible Book Value	6.4	5.02	3.7	18.34	11.43
Tangible Book Value Per Share	0.24	0.21	0.19	0.94	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.